# NEW ENGLAND RESEARCH INSTITUTES, INC.: 2/2 Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | NEW ENGLAND RESEARCH INSTITUTES, INC. |
| Location | Wilmington, DE |
| Project | 2/2 Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy |
| Project number | 1U24HL185609-01 |
| Mechanism | U24 |
| Institute | National Heart Lung and Blood Institute |
| Award | $806,069 |
| Awarded | 2026-09-08 |
| Project period | 2026-09-07 to 2032-08-31 |
| UEI | FFWJTXCKDLK5 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11351068). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.